Skip to main content
MASIMO CORP logo

MASIMO CORP — Investor Relations & Filings

Ticker · MASI ISIN · US5747951003 LEI · 549300Q4A8JK0PIYCU29 US Manufacturing
Open in API
Filings indexed 1,253 across all filing types
Latest filing 2022-09-27 Major Shareholding Noti…
Country US United States of America
Listing US MASI

About MASIMO CORP

https://www.masimo.com/

Masimo is a global medical technology company that develops, manufactures, and markets a wide array of noninvasive patient monitoring technologies. The company's core offering is its proprietary Signal Extraction Technology (SET®) pulse oximetry, renowned for its ability to provide accurate measurements during patient motion and low peripheral perfusion. Masimo's product portfolio also includes advanced solutions for brain function monitoring (SedLine®), regional oximetry (O3®), and integrated patient monitoring and connectivity platforms like Root®. These technologies are designed to improve patient outcomes, enhance patient safety, and streamline clinical workflows in various healthcare settings, including hospitals, emergency medical services, and home care. The company focuses on creating innovative solutions that empower clinicians with reliable data to make critical care decisions.

Recent filings

Filing Released Lang Actions
SCHEDULE 13D (AMENDMENT NO. 1)
Major Shareholding Notification
2022-09-27 English
FORM 3
Director's Dealing
2022-09-27 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on the appointment of a new Chief Operating Officer, including details about the individual's background, compensation, and related agreements. There is no financial statement or comprehensive financial data presented. The primary subject is a management change announcement. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 7658 characters, which is sufficient to contain detailed information about the management change, not just a brief announcement or a report publication notice. Therefore, the correct classification is MANG with high confidence.
2022-09-19 English
8-A12B
Regulatory Filings Classification · 95% confidence The document is a Form 8-A filed with the SEC, which is used for the registration of certain classes of securities pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934. The text describes the issuance of rights related to the company's common stock, including detailed terms of the rights, distribution dates, triggering events, redemption, and exchange provisions. This is a regulatory filing related to securities registration and rights issuance, not a financial report, earnings release, or management discussion. It does not fit into categories like Annual Report, Earnings Release, or Proxy Solicitation. It is a specific regulatory filing form used to register securities and disclose related information. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a report publication announcement but a substantive regulatory filing.
2022-09-09 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the declaration of a dividend distribution of rights related to common stock, details about the rights agreement, issuance, exercise, redemption, and other terms. This is an announcement of a material definitive agreement and related corporate actions, not a full financial report or earnings release. It does not contain comprehensive financial statements or detailed management discussion. Therefore, it fits best under the category of Capital/Financing Update (CAP), as it relates to issuance of rights and potential changes in capital structure.
2022-09-09 English
SCHEDULE 13D
Major Shareholding Notification
2022-08-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.